La Pitié Salpétrière Hospital
Welcome,         Profile    Billing    Logout  
 23 Trials 
14 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ratziu, Vlad
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
B-Well 2, NCT05630820 / 2022-002268-53: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B

Active, not recruiting
3
871
Europe, Canada, Japan, US, RoW
Bepirovirsen, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Chronic Hepatitis B, Hepatitis B, Chronic
11/25
05/26
HORIZON, NCT05583344 / 2022-002538-14: Phase 2b Study of GSK4532990 in Adults With NASH

Active, not recruiting
2
284
Europe, Canada, Japan, US, RoW
GSK4532990, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
01/26
04/27
M148, NCT06519331: Development of a New Method for Liver Stiffness Measurement Using FibroScan

Not yet recruiting
N/A
114
Europe
Research FibroScan (FS)
Echosens
Liver Diseases
10/26
05/27
DPAILO-1, NCT06344364: Digital Pathology and AI for Liver Outcomes in MASLD

Not yet recruiting
N/A
1800
Europe, RoW
Digital Pathology FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS)
PharmaNest, Inc, Chinese University of Hong Kong, University of Edinburgh, University of Seville, Imperial College London, Icahn School of Medicine at Mount Sinai, Fundacio Clinic Barcelona, Sorbonne University, Newcastle University
Metabolic Dysfunction-associated Steatotic Liver Disease
05/25
07/25
NCT05479721: LITMUS Imaging Study

Active, not recruiting
N/A
450
Europe, US
University of Oxford, Newcastle University, University of Nottingham, University of Cambridge, University of Seville, Pinnacle Clinical Research, PLLC, ICAN Nutrition Education and Research, Assistance Publique - Hôpitaux de Paris, University of Angers, University of Palermo, University of Turin, Italy, University Medical Center Mainz, University of Helsinki, University of Bern, Linkoeping University, Perspectum, Antaros Medical, Resoundant Inc, Pfizer, Novartis, Takeda, Intercept Pharmaceuticals, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Boehringer Ingelheim
NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver
10/25
10/25
roux, christian h
CRI-RA, NCT04870203: Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis

Recruiting
3
178
Europe, RoW
baricitinib treatment, anti-TNF therapy, Placebo
University Hospital, Bordeaux, Eli Lilly and Company, Biogen, Ministry for Health and Solidarity, France
Rheumatoid Arthritis
12/26
12/26
BACHELOR, NCT04027101: BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica

Completed
2
34
Europe
Baricitinib, Placebos
University Hospital, Brest, Eli Lilly and Company
Polymyalgia Rheumatic (PMR)
08/23
08/23
NCT05848258: An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

Recruiting
2
380
Europe, US, RoW
LY3871801, Placebo
Eli Lilly and Company, Rigel Pharmaceuticals
Rheumatoid Arthritis
02/26
07/26
SAPHIR, NCT05598684: : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases

Recruiting
N/A
600
Europe, RoW
Fresenius Kabi, France
Crohn Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
09/25
12/25
EPROGE, NCT06466330: Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial

Recruiting
N/A
112
Europe
microparticles, embolization, sham embolization
Societe Francaise de Rhumatologie, Centre Hospitalier Universitaire de Nice, Euraxi Pharma
Knee Pain Chronic, Knee Pain Swelling
02/26
02/27
Zemouri, Sofia
FLUO, NCT05409612 / 2021-002691-39: Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients

Completed
3
206
Europe
Supemtek®, Vaxigriptetra®
Assistance Publique - Hôpitaux de Paris, Sanofi Pasteur, a Sanofi Company, Hospices Civils de Lyon
Morbid Obesity, Severe Obesity
04/23
10/23
Mathon, Bertrand
EPILITT, NCT05198882: Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy

Recruiting
1
13
Europe
Laser technology for intracerebral thermocoagulation
Assistance Publique - Hôpitaux de Paris, Medtronic
Drug-resistant Focal Epilepsy, Epilepsy, Epilepsies, Focal, Focal Epilepsy, Drug Resistant
09/23
08/24
SAPPHYRE, NCT04746625: Safety and Performance of the Polaris® 24 Adjustable Valve System in Hydrocephalus Patients' Treatment

Recruiting
N/A
126
Europe
Sophysa
Hydrocephalus
06/24
06/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ratziu, Vlad
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
B-Well 2, NCT05630820 / 2022-002268-53: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B

Active, not recruiting
3
871
Europe, Canada, Japan, US, RoW
Bepirovirsen, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Chronic Hepatitis B, Hepatitis B, Chronic
11/25
05/26
HORIZON, NCT05583344 / 2022-002538-14: Phase 2b Study of GSK4532990 in Adults With NASH

Active, not recruiting
2
284
Europe, Canada, Japan, US, RoW
GSK4532990, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
01/26
04/27
M148, NCT06519331: Development of a New Method for Liver Stiffness Measurement Using FibroScan

Not yet recruiting
N/A
114
Europe
Research FibroScan (FS)
Echosens
Liver Diseases
10/26
05/27
DPAILO-1, NCT06344364: Digital Pathology and AI for Liver Outcomes in MASLD

Not yet recruiting
N/A
1800
Europe, RoW
Digital Pathology FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS)
PharmaNest, Inc, Chinese University of Hong Kong, University of Edinburgh, University of Seville, Imperial College London, Icahn School of Medicine at Mount Sinai, Fundacio Clinic Barcelona, Sorbonne University, Newcastle University
Metabolic Dysfunction-associated Steatotic Liver Disease
05/25
07/25
NCT05479721: LITMUS Imaging Study

Active, not recruiting
N/A
450
Europe, US
University of Oxford, Newcastle University, University of Nottingham, University of Cambridge, University of Seville, Pinnacle Clinical Research, PLLC, ICAN Nutrition Education and Research, Assistance Publique - Hôpitaux de Paris, University of Angers, University of Palermo, University of Turin, Italy, University Medical Center Mainz, University of Helsinki, University of Bern, Linkoeping University, Perspectum, Antaros Medical, Resoundant Inc, Pfizer, Novartis, Takeda, Intercept Pharmaceuticals, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Boehringer Ingelheim
NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver
10/25
10/25
roux, christian h
CRI-RA, NCT04870203: Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis

Recruiting
3
178
Europe, RoW
baricitinib treatment, anti-TNF therapy, Placebo
University Hospital, Bordeaux, Eli Lilly and Company, Biogen, Ministry for Health and Solidarity, France
Rheumatoid Arthritis
12/26
12/26
BACHELOR, NCT04027101: BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica

Completed
2
34
Europe
Baricitinib, Placebos
University Hospital, Brest, Eli Lilly and Company
Polymyalgia Rheumatic (PMR)
08/23
08/23
NCT05848258: An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

Recruiting
2
380
Europe, US, RoW
LY3871801, Placebo
Eli Lilly and Company, Rigel Pharmaceuticals
Rheumatoid Arthritis
02/26
07/26
SAPHIR, NCT05598684: : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases

Recruiting
N/A
600
Europe, RoW
Fresenius Kabi, France
Crohn Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
09/25
12/25
EPROGE, NCT06466330: Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial

Recruiting
N/A
112
Europe
microparticles, embolization, sham embolization
Societe Francaise de Rhumatologie, Centre Hospitalier Universitaire de Nice, Euraxi Pharma
Knee Pain Chronic, Knee Pain Swelling
02/26
02/27
Zemouri, Sofia
FLUO, NCT05409612 / 2021-002691-39: Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients

Completed
3
206
Europe
Supemtek®, Vaxigriptetra®
Assistance Publique - Hôpitaux de Paris, Sanofi Pasteur, a Sanofi Company, Hospices Civils de Lyon
Morbid Obesity, Severe Obesity
04/23
10/23
Mathon, Bertrand
EPILITT, NCT05198882: Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy

Recruiting
1
13
Europe
Laser technology for intracerebral thermocoagulation
Assistance Publique - Hôpitaux de Paris, Medtronic
Drug-resistant Focal Epilepsy, Epilepsy, Epilepsies, Focal, Focal Epilepsy, Drug Resistant
09/23
08/24
SAPPHYRE, NCT04746625: Safety and Performance of the Polaris® 24 Adjustable Valve System in Hydrocephalus Patients' Treatment

Recruiting
N/A
126
Europe
Sophysa
Hydrocephalus
06/24
06/28

Download Options